Peptides that mimic the function of HDL cholesterol, which has been dubbed "good cholesterol," can treat the underlying inflammation associated with inflammatory bowel disease, or IBD, according to new research in mice. The ...
Jun 12, 2019
0
2
With Alex Trebek's recent announcement that his pancreatic cancer is in remission, many people have wondered if this difficult cancer is now easier to treat. Pancreatic cancer remains a major cancer killer, but advances are ...
May 31, 2019
0
4
AKR1B10 is a useful serum biomarker for advanced liver fibrosis in Nonalcoholic steatohepatitis, and combined with serum WFA(+)-M2BP, it can predict hepatocellular carcinoma development, gastroesophageal varix formation, ...
Apr 12, 2019
0
0
Colorectal cancer is the second leading cause of death from cancer in North America and is often diagnosed at an advanced stage, after it has spread to other parts of the body. Patients with advanced colorectal cancer generally ...
Feb 18, 2019
0
4
A new study in JNCI Cancer Spectrum has identified a connection between prolonged time spent sitting while watching TV and increased risk of colorectal cancer for younger Americans.
Feb 05, 2019
0
8
An international team of researchers has identified a novel route that regulates the signaling pathways induced by extracellular matrix (ECM). This may serve as a new diagnostic marker and therapeutic target in the fight ...
Jan 21, 2019
0
0
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumours of the head and neck, i.e. in the mouth, the pharynx ...
Jan 17, 2019
0
0
Novel Technique Can Potentially Improve Success of Ovarian Cancer Treatment, Study Reveals
Oct 30, 2018
0
18
A study from Fred Hutchinson Cancer Research Center that will be presented at the American Society of Clinical Oncology annual meeting on June 5 in Chicago shows that asymptomatic women who have been treated for early-stage ...
May 25, 2017
0
0
Postmenopausal women with breast cancer who took aromatase inhibitors demonstrated endothelial dysfunction, a predictor of cardiovascular disease, according to study results presented at the 2016 San Antonio Breast Cancer ...
Dec 12, 2016
0
20
